Global Eperisone Market Research Report 2022

Eperisone is a central muscle relaxant.Acting on the spinal cord and vascular smooth muscle, it can reduce the sensitivity of muscle spindle by inhibiting the spinal cord reflex, inhibiting the spontaneous impulse of the myomotor neurons, and thus relieving the tension of skeletal muscle.And through the expansion of blood vessels and improve blood circulation, from many aspects to block muscle tension hyperactivity → circulation disorder → muscle pain → muscle tension hyperactivity this kind of skeletal muscle tension vicious circle.
Due to the COVID-19 pandemic, the global Eperisone market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Eperisone market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Eperisone landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Particles accounting for % of the Eperisone global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Neck Shoulder Wrist Syndrome segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Eperisone include Navipharm, Daewon, Hanmi, Eisai, Bracco, Zambon, Hunan Yada Pharmaceutical and Qingdao Guohai Biopharmaceutical, etc. In terms of revenue, the global 3 largest players have a % market share of Eperisone in 2021.
This report focuses on Eperisone volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Eperisone market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Eperisone Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Particles
Tablets
Segment by Application
Neck Shoulder Wrist Syndrome
Shoulder Periarthritis
Lumbar Pains
Spastic Paralysis
Musculoskeletal Pain
Systemic Traumatic Pain
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Navipharm
Daewon
Hanmi
Eisai
Bracco
Zambon
Hunan Yada Pharmaceutical
Qingdao Guohai Biopharmaceutical